| Teratogenicity of sodium valproate | 2005/03/01 | English | 123 |
| Safety of benzodiazepines in the geriatric population | 2004/09/01 | English | 123 |
| Safety and tolerability of available urate-lowering drugs: a critical review | 2019/03/27 | English | 121 |
| EGFR TKI combination with immunotherapy in non-small cell lung cancer | 2017/03/08 | English | 121 |
| Revisiting doxycycline in pregnancy and early childhood – time to rebuild its reputation? | 2016/01/25 | English | 118 |
| How safe is the use of thiazolidinediones in clinical practice? | 2008/11/25 | English | 117 |
| Idiosyncratic drug-induced liver injury: an overview | 2007/10/30 | English | 116 |
| An update on the safety of SGLT2 inhibitors | 2019/04/03 | English | 115 |
| Drugs with anticholinergic properties: a current perspective on use and safety | 2011/06/02 | English | 115 |
| The potential adverse effects of habitual use ofCatha edulis(khat) | 2005/10/28 | English | 115 |
| Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis | 2020/03/03 | English | 114 |
| Everolimus and sirolimus in transplantation-related but different | 2015/04/26 | English | 114 |
| The side effects of the prostaglandin analogues | 2006/12/20 | English | 110 |
| Naloxone treatment in opioid addiction: the risks and benefits | 2007/03/01 | English | 108 |
| The multiple faces of quercetin in neuroprotection | 2009/06/21 | English | 105 |
| Reactivation of hepatitis B virus with rituximab | 2005/05/01 | English | 105 |
| Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel | 2015/04/24 | English | 103 |
| The economic burden of preventable adverse drug reactions: a systematic review of observational studies | 2018/07/03 | English | 103 |
| Toxicities of the platinum antineoplastic agents | 2003/11/01 | English | 101 |
| Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable | 2007/10/30 | English | 99 |
| Statin drug interactions and related adverse reactions: an update | 2017/10/30 | English | 99 |
| Gemcitabine: vascular toxicity and prothrombotic potential | 2008/11/01 | English | 99 |
| Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) | 2017/05/09 | English | 98 |
| Anticholinergics: theoretical and clinical overview | 2016/03/30 | English | 97 |
| The safety of gliptins : updated data in 2018 | 2018/03/03 | English | 96 |
| Adalimumab: a review of side effects | 2005/07/01 | English | 96 |
| Renal toxicity associated with tenofovir use | 2010/04/13 | English | 94 |
| Serotonergic drugs and valvular heart disease | 2009/05/01 | English | 94 |
| The efficacy and safety of amifostine for the acute radiation syndrome | 2019/09/17 | English | 94 |
| Cancer immunotherapies, their safety and toxicity | 2013/05/14 | English | 92 |